• This record comes from PubMed

Artificially low cortical bone mineral density in Turner syndrome is due to the partial volume effect

. 2015 Mar ; 26 (3) : 1213-8. [epub] 20141007

Language English Country England, Great Britain Media print-electronic

Document type Journal Article, Research Support, Non-U.S. Gov't

UNLABELLED: We aimed to show that the decrease in the cortical bone mineral density (BMD) in the radius in Turner syndrome (TS) is artificially caused by the partial volume effect. We confirmed that the partial volume effect-corrected cortical BMD is not decreased in TS compared to in the healthy controls. Other factors are responsible for the increased fracture rate in TS. INTRODUCTION: Decreased cortical bone mineral density (BMD) has been reported in Turner syndrome (TS), using peripheral quantitative computerised tomography, and it is perceived as one of the major factors leading to increased fracture risk. We tested the hypothesis that low cortical BMD in the radius is caused artificially by the partial volume effect. METHODS: A cross-sectional study was conducted at the university hospital referral centre between March and October 2013. Thirty-two participants with TS who consented to the study were included (mean age 15.3 ± 3.2 years). We assessed the cortical BMD in the radius as well as the tibia, where the cortex is thicker compared with the radius. RESULTS: Whereas the cortical BMD was decreased in the radius (mean ± SD Z-score -0.6 ± 1.5, p = 0.037), it was increased in the tibia (mean Z-score 0.83 ± 1.0, p < 0.001). After correcting the cortical BMD for the partial volume effect, the mean Z-score was normal in the radius in TS (0.4 ± 1.3, p = 0.064). The corrected cortical BMD values were similar in the radius and tibia (1108 ± 52 vs. 1104 ± 48, group difference p = 0.75). CONCLUSIONS: The cortical BMD is not decreased in TS. The partial volume effect is responsible for previous findings of decreased cortical BMD in the radius. Altered bone geometry or other factors rather than low cortical BMD likely play a role in the increased fracture risk in TS.

See more in PubMed

Osteoporos Int. 2001;12(7):538-47 PubMed

Pediatr Neurol. 1996 Nov;15(4):317-22 PubMed

Osteoporos Int. 2010 Dec;21(12):2093-9 PubMed

J Clin Densitom. 2005 Winter;8(4):461-6 PubMed

Clin Endocrinol (Oxf). 2011 Apr;74(4):445-52 PubMed

Clin Endocrinol (Oxf). 2003 Jul;59(1):89-96 PubMed

J Clin Densitom. 2008 Apr-Jun;11(2):283-94 PubMed

J Bone Miner Res. 2000 Oct;15(10):2005-10 PubMed

Bone. 2013 Aug;55(2):377-83 PubMed

Clin Endocrinol (Oxf). 1999 Oct;51(4):497-502 PubMed

J Clin Endocrinol Metab. 2006 Oct;91(10):3897-902 PubMed

J Musculoskelet Neuronal Interact. 2004 Dec;4(4):436-41 PubMed

J Clin Endocrinol Metab. 2013 Jul;98(7):E1241-7 PubMed

J Bone Miner Res. 2012 Aug;27(8):1794-803 PubMed

Cent Eur J Public Health. 2004 Sep;12(3):126-30 PubMed

J Clin Endocrinol Metab. 2004 Jan;89(1):193-9 PubMed

J Clin Densitom. 2000 Spring;3(1):9-14 PubMed

J Bone Miner Res. 2009 Jun;24(6):1075-85 PubMed

J Clin Endocrinol Metab. 2002 Jun;87(6):2798-808 PubMed

J Musculoskelet Neuronal Interact. 2008 Jul-Sep;8(3):217-26 PubMed

Horm Res Paediatr. 2011;76(3):193-201 PubMed

J Musculoskelet Neuronal Interact. 2013 Mar;13(1):89-96 PubMed

J Clin Endocrinol Metab. 2001 Dec;86(12):5819-23 PubMed

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...